Sheraton, who specialises in patent litigation and life sciences, will be part of the global IP group.
He trained as a medicinal chemist in industry and has advised clients in the fields of microarray technology, enzymatic research tools, antibody production, microfluidics and medical devices.
He has also contributed comment and articles to Managing IP, including:
Pharma industry attacked over patent strategies
